Skip to main content Skip to navigation

Macrocystic Lymphatic Malformation

Last updated: February 8, 2026 Medically reviewed by: RxHarun Orthopedic Specialist Doctor Reading time: 30 min read

Macrocystic lymphatic malformation (macrocystic LM) is a type of lymphatic malformation, which means it is an abnormal cluster of lymph vessels and fluid-filled spaces that develops before birth. It is benign (not cancer), but it can grow large and press on nearby organs. In a macrocystic lesion, the cysts are big, usually more than 1–2 cm, and filled with clear lymph fluid. These cysts form soft, smooth, often lobulated lumps under the skin.Radiopaedia+2ScienceDirect+2

Lymphatic malformations are slow-flow vascular malformations in the ISSVA (International Society for the Study of Vascular Anomalies) classification. They are not tumors that grow because of fast cell division, but instead are structural errors in how the lymph system formed in the embryo. Most macrocystic lymphatic malformations are present at birth or appear in early childhood, especially in the neck, face, armpit, chest or mediastinum, but they can also occur in the abdomen, limbs, or other body areas.ISSVA+2Radiopaedia+2

A macrocystic lymphatic malformation is a non-cancer (benign) birth condition made of abnormal lymph vessels that form large, fluid-filled pockets (cysts), often in the neck, armpit, chest, face, tongue, or body wall. “Macro” means the cyst spaces are usually big enough to see on imaging and often to feel, and they can slowly grow, swell fast during illness, or press on nearby parts like the airway. Many experts also call it cystic hygroma (especially in the neck). ISSVA+2PMC+2

Why it happens

MLM happens when the lymph “drain pipes” do not form normally before birth, so lymph fluid collects inside cysts instead of moving through normal channels. Some cases are linked to genetic pathway changes (often the PI3K/AKT/mTOR pathway), which can make lymph vessel cells grow or behave abnormally. This is why “targeted medicines” are sometimes used for difficult cases in specialist centers. ScienceDirect+2Neurointervention+2

Although macrocystic LM is benign, it can cause serious problems if it compresses the airway, swallowing tube, major blood vessels, or nerves. The swelling may suddenly enlarge if it bleeds or becomes infected, which may turn a quiet lesion into an emergency situation. Because of this, early recognition, careful monitoring, and proper imaging are very important.DermNet®+2Cincinnati Children’s Hospital+2

Other names

Doctors and older textbooks use several different names for macrocystic lymphatic malformation. Common synonyms include:

  • Cystic hygroma

  • Cystic lymphangioma

  • Macrocystic lymphangioma

  • Cystic lymphatic malformation

  • Lymphangioma cysticum

  • Cystic lymphatic tumor (older, less preferred term)

Today, experts prefer the term lymphatic malformation rather than lymphangioma or cystic hygroma, because it better reflects that this is a malformation of vessels rather than a true tumor.DermNet®+2Wikipedia+2

Although this article focuses on macrocystic LM, it helps to see where it fits among related types:

  • Macrocystic lymphatic malformation – large, well-defined cysts filled with lymph fluid; often in neck, axilla, chest, or abdomen.

  • Microcystic lymphatic malformation – many tiny cysts like a sponge; often seen on skin and mucosa, such as mouth or limbs.

  • Mixed macro- and microcystic LM – a combination of large and small cysts in the same lesion.

  • Isolated LM – lymphatic malformation alone without other vessel problems.

  • Combined LM – LM mixed with other vascular malformations (such as venous malformation) in the same area.LGD Alliance+3Cincinnati Children’s Hospital+3Compendium Vascular Anomalies+3

Causes of macrocystic lymphatic malformation

Each “cause” below is really a factor or mechanism that may contribute. In many babies, no clear single cause is found.

  1. Abnormal lymphatic development in the embryo
    The main cause is a structural error when the lymphatic system forms in early pregnancy. Some lymph sacs or channels do not connect properly to the main lymph network. Trapped sacs slowly expand into cysts and become a macrocystic lymphatic malformation.PMC+2ScienceDirect+2

  2. Failure of lymphatic sacs to join the central system
    Normally, primitive lymph sacs connect to larger veins and lymph trunks. If this connection does not happen, the isolated sacs keep collecting lymph fluid. Over time they enlarge and form one or several big cysts in the neck, chest or abdomen.PMC+1

  3. Sporadic (random) developmental error
    Most macrocystic LMs occur sporadically, meaning they happen by chance with no family history. A random error during tissue development can affect just one small area, while the rest of the baby develops normally.Dr. Bastidas+1

  4. Genetic changes in growth pathways (e.g., PIK3CA, VEGFR3)
    Research has found mutations in genes like PIK3CA and VEGFR3 (FLT4) in some lymphatic malformations. These genes control lymph vessel growth and signaling. When they are altered, lymphatic cells may form abnormal, enlarged channels and cysts.MDPI+1

  5. Turner syndrome
    Cystic hygroma (macrocystic LM) is frequently seen in fetuses with Turner syndrome (45,X or related karyotypes). The abnormal sex chromosome pattern appears to disturb lymphatic development in the neck and upper body, leading to large cystic neck swellings.Cleveland Clinic+1

  6. Down syndrome (trisomy 21)
    Some babies with macrocystic lymphatic malformations also have Down syndrome. The extra chromosome 21 may be linked to changes in lymphatic and vascular development, although the exact mechanism is still under study.Cleveland Clinic+1

  7. Noonan syndrome
    Noonan syndrome is another genetic condition associated with neck cystic hygromas in the fetus. Mutations in RAS-MAPK pathway genes can affect lymphatic vessel formation, leading to large cystic malformations.Wikipedia+1

  8. Other genetic / syndromic conditions
    Rare syndromes such as Hennekam lymphangiectasia syndrome or certain complex vascular anomaly syndromes can include lymphatic malformations as part of their picture. In these cases, LM is one feature of a broader genetic disorder.RSNA Publications+1

  9. Family history of vascular or lymphatic malformations
    Most cases are not inherited, but occasional families show more than one member with lymphatic or related vascular malformations. This suggests that inherited variants in genes controlling vessel development can increase risk in some families.MDPI+1

  10. Chromosomal imbalance detected on prenatal testing
    Some fetuses with macrocystic neck lesions show chromosomal deletions, duplications, or other imbalances on karyotype or chromosomal microarray. These changes may interfere with normal lymphatic and vascular development.Wikipedia+1

  11. General problems in fetal fluid handling (hydrops, severe edema)
    When a fetus has hydrops (severe body swelling and fluid buildup), the overloaded lymphatic system may not drain properly. This situation can be associated with or worsen large cystic lymphatic malformations in the neck or chest.Wikipedia+1

  12. Localized venous outflow problems in the neck or chest
    If venous blood drainage from a region is abnormal, it can increase pressure around lymph vessels. Over time, this may promote dilation of lymph channels and enlargement of pre-existing small malformations into macrocystic lesions.Cosmoderma+1

  13. Trauma or bleeding inside a pre-existing small LM
    A minor injury, birth trauma, or internal bleeding into a small, unrecognized lymphatic malformation can suddenly expand the cystic spaces. This can transform a subtle lesion into a large macrocystic swelling.PMC+1

  14. Infection of lymphatic channels (lymphangitis)
    Infection in or near a lymphatic malformation can cause inflammation, fluid accumulation, and clotting inside lymph spaces. The inflamed lesion may enlarge, and repeated episodes can remodel small channels into larger cysts.DermNet®+1

  15. Rapid growth during childhood
    As a child grows, the macrocystic lymphatic malformation can grow as well. Growth spurts may make a previously small lesion more obvious or symptomatic, even though the basic malformation has been present since birth.KidsHealth+1

  16. Hormonal changes during puberty
    Puberty brings hormonal and body-size changes that can alter blood and lymph flow. Some macrocystic LMs become larger, softer, or more symptomatic during adolescence for this reason.Dr. Bastidas+1

  17. Pregnancy in adults with pre-existing LM
    In adults who still have lymphatic malformations, pregnancy increases blood volume and fluid shifts. This may enlarge cysts or make symptoms worse, especially in the neck, chest, or extremities.ScienceDirect+1

  18. Previous surgery or radiation near lymph drainage pathways
    In rare acquired cases, surgical removal of lymph nodes or radiation therapy may disrupt lymph flow and lead to abnormal lymphatic channels and cysts in nearby tissues. This is more often linked with lymphatic obstruction, but macrocystic changes can occur.ScienceDirect+1

  19. Co-existing venous or arteriovenous malformations
    Combined vascular malformations (for example, capillary-lymphatic-venous malformations) can disturb local pressure and flow, causing some lymphatic components to dilate into macrocystic spaces.ISSVA+2Radiopaedia+2

  20. Unknown / idiopathic factors
    Even with modern genetics and imaging, many macrocystic lymphatic malformations have no identifiable trigger beyond “developmental error.” For many families, the most accurate explanation is that it happened by chance during early fetal development.ScienceDirect+1

Symptoms and signs of macrocystic lymphatic malformation

  1. Soft, painless lump under the skin
    The most common early sign is a soft, squishy swelling that feels like a water-filled bag. It usually does not hurt and may change slightly in size from day to day. Parents often notice it in the neck, armpit, chest, or face.DermNet®+2Cincinnati Children’s Hospital+2

  2. Visible swelling in the neck or face
    Macrocystic LMs often appear in the side or back of the neck or around the jaw. The swelling can distort the outline of the neck or face, sometimes causing visible asymmetry even in a newborn.Cleveland Clinic+1

  3. Skin color changes over the mass
    The skin over the lesion may look normal, slightly bluish, or reddish-blue. Because the cysts are filled with clear lymph and sometimes a bit of blood, they can give the skin a translucent or “transparent” look.DermNet®+1

  4. Sudden increase in size
    The mass can suddenly enlarge if there is bleeding into a cyst or if the lesion becomes infected. This rapid change often brings the child to urgent medical attention, especially if it affects breathing or swallowing.PMC+1

  5. Pain or tenderness in the swelling
    Most of the time, macrocystic LMs are painless. However, pain and tenderness can appear if the cysts are inflamed, infected, or under high tension from rapid fluid build-up.DermNet®+1

  6. Redness and warmth over the lesion
    If infection occurs, the skin on top of the lesion may become red, warm, and slightly firm. The child may also feel unwell, with fever or irritability. This is a warning sign that needs quick medical review.DermNet®+1

  7. Breathing difficulty (airway obstruction)
    A large neck or chest macrocystic LM can press on the airway and make it hard for the baby to breathe. Signs include noisy breathing, fast breathing, chest retractions, or episodes of turning blue. In severe cases this is an emergency.Cleveland Clinic+2Cincinnati Children’s Hospital+2

  8. Noisy breathing or stridor
    Stridor is a high-pitched noise when air passes through a narrowed airway. A mass that pushes on the windpipe or voice box can cause this sound, especially when the child is crying or lying down.Cincinnati Children’s Hospital+1

  9. Trouble swallowing or feeding
    If the lesion presses on the esophagus or mouth, the baby may have trouble sucking, swallowing, or moving food through the throat. This can lead to gagging, choking, poor feeding, or weight gain problems.Cincinnati Children’s Hospital+1

  10. Drooling and gagging during feeds
    Some babies drool a lot or cough and gag while feeding because the mass narrows the space in the mouth and throat. This difficulty may be worse when the child is lying flat.

  11. Snoring or disturbed sleep
    Older children may snore or sleep with their neck in unusual positions to keep the airway open. Large neck or facial lesions can contribute to sleep-disordered breathing or pauses in breathing at night.

  12. Recurrent respiratory infections
    If airway clearance is poor or if the mass causes partial blockage, the child may get frequent chest infections, wheezing, or bronchitis. Infections of the LM itself can also trigger fevers and malaise.Cincinnati Children’s Hospital+1

  13. Limited movement of nearby joint or limb
    Macrocystic LMs in the armpit, chest wall, or limb can restrict range of motion. The child may avoid lifting the arm fully or may limp if the lesion is in the thigh or groin.ScienceDirect+1

  14. Bleeding into the cyst (hemorrhage)
    Sometimes small blood vessels inside the lesion break and bleed into the lymph cysts. The swelling becomes suddenly larger, firmer, and painful, and the overlying skin may turn darker or bruised.DermNet®+1

  15. Cosmetic and emotional impact
    Visible deformities of the face or neck can cause distress, shyness, or bullying, especially for school-age children and teenagers. Even when the lesion is medically stable, its appearance can strongly affect quality of life and self-esteem.KidsHealth+1

Diagnostic tests for macrocystic lymphatic malformation

Doctors combine the story (history), physical exam, and targeted tests to confirm a macrocystic lymphatic malformation and plan treatment.

Physical examination tests

  1. Visual inspection of the swelling
    The doctor looks at the size, shape, borders, and skin changes of the swelling. Macrocystic LM often appears as a soft, lobulated mass with normal, bluish, or reddish skin. The doctor also checks for signs of infection or rapid growth.DermNet®+2Cincinnati Children’s Hospital+2

  2. Palpation (feeling the mass with the hands)
    By gently pressing the swelling, the doctor can tell if it feels soft, cystic, compressible, or firm. Macrocystic LMs usually feel like soft, fluid-filled sacs and may partly flatten under gentle pressure, helping to distinguish them from solid tumors.Radiopaedia+1

  3. Transillumination test with a light
    A bright light is shone through the mass in a dark room. Clear fluid-filled cysts transmit light and look like a glowing balloon, supporting the diagnosis of a cystic lesion such as macrocystic LM. Solid masses or those full of thick blood do not transilluminate as well.DermNet®+1

  4. Airway and breathing assessment
    The doctor listens to breathing sounds, looks for chest retractions, and checks oxygen level. If the mass is near the airway, they watch for stridor, noisy breathing, or signs of respiratory distress, which helps decide how urgent the situation is.Cincinnati Children’s Hospital+1

Manual tests

  1. Manual compression test
    The doctor presses gently but firmly on the swelling to see if it compresses and refills. A macrocystic LM often compresses easily and slowly refills with fluid, while a solid tumor or stiff malformation will not change as much.

  2. Posture and position change observation
    The lesion is observed when the child is lying down, sitting, or standing. Some lymphatic malformations change size slightly with gravity or pressure changes, and this can give clues about their nature and how they affect breathing or swallowing.

  3. Range of motion testing of nearby joints
    If the LM is near a shoulder, hip, or limb, the doctor gently moves the joint to see whether the mass restricts movement or causes discomfort. This helps assess functional impact and guides decisions about timing and type of treatment.

  4. Swallowing and feeding evaluation
    For neck or oropharyngeal lesions, the clinician watches the child feed or swallow water. They look for coughing, gagging, or difficulty moving food. This simple manual observation test helps identify risk of aspiration and the need for more detailed studies.Cincinnati Children’s Hospital+1

Lab and pathological tests

  1. Complete blood count (CBC)
    A CBC checks red and white blood cells and platelets. It does not diagnose LM directly, but can show signs of infection (raised white cells) or anemia from bleeding into the lesion. It is also important before surgery or invasive procedures.

  2. Inflammatory markers (CRP, ESR)
    Blood tests such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) rise when there is inflammation or infection. These markers support the diagnosis of an infected LM if the child has fever, redness, or pain in the lesion.

  3. Coagulation profile (clotting tests)
    Tests like PT, aPTT, and fibrinogen measure how well the blood clots. They help assess surgical risk and screen for consumption of clotting factors in very large or complex vascular malformations.

  4. Genetic and chromosomal studies
    In fetuses or infants with large neck LMs, doctors may suggest karyotype or chromosomal microarray to look for Turner syndrome, Down syndrome, Noonan syndrome, or other genetic changes. In some centers, targeted gene panels for vascular anomalies are also used.Wikipedia+2MDPI+2

  5. Histopathology of the lesion (tissue examination)
    When the lesion is surgically removed or biopsied, a pathologist examines it under a microscope. Classic features include dilated lymphatic spaces lined by endothelial cells, separated by fibrous tissue and sometimes smooth muscle. This confirms that the mass is a lymphatic malformation and not another tumor.ScienceDirect+1

Electrodiagnostic tests

  1. Nerve conduction studies
    If a large LM lies near major nerves and the child has weakness, numbness, or tingling, nerve conduction studies may be used. These tests send small electrical impulses through nerves to see how well signals travel, helping assess nerve compression.

  2. Electromyography (EMG)
    EMG measures the electrical activity of muscles. If the LM compresses nerves supplying a limb or facial muscles, EMG can show signs of nerve injury or chronic denervation, which may influence the need for decompressive surgery.

Imaging tests

  1. Ultrasound of the lesion
    Ultrasound is usually the first imaging test. It uses sound waves to show cystic spaces, their size, number, and depth. Macrocystic LMs appear as large, clear, fluid-filled areas often with thin internal walls (septa). Ultrasound also guides needle drainage or sclerotherapy.Compendium Vascular Anomalies+2Medscape+2

  2. Prenatal obstetric ultrasound
    Many macrocystic LMs are first discovered on routine pregnancy scans, especially in the second trimester. A large, cystic neck mass or nuchal cystic hygroma can be seen, prompting further genetic testing and planning for delivery at a specialized center.Wikipedia+1

  3. Magnetic resonance imaging (MRI)
    MRI provides detailed pictures of soft tissues and is considered the gold standard for defining the full extent of lymphatic malformations, especially in the head and neck. It shows multiloculated cystic masses, their relation to airway, blood vessels, nerves, and spine, and helps plan surgery or sclerotherapy.Medscape+2Ej Radiology+2

  4. Computed tomography (CT) scan
    CT uses X-rays to create cross-sectional images. It is less commonly needed in children because of radiation, but may be used in urgent situations or to evaluate chest, abdominal, or bone involvement. CT shows low-density cystic areas and their effect on nearby structures.Medscape+1

  5. Lymphoscintigraphy or MR lymphangiography
    These specialized imaging tests trace the flow of lymph fluid using contrast agents. They are mainly used in complex or widespread disease to understand how lymph drains, to map connections to normal lymphatics, and sometimes to guide interventional procedures or surgery.Compendium Vascular Anomalies+2AJR American Journal of Roentgenology+2

Non-pharmacological treatments (therapies and others)

  1. Watchful waiting (active monitoring): Small, painless lesions may be watched with regular checkups and imaging. Purpose: avoid unnecessary risks. Mechanism: some remain stable; treatment is used when symptoms, growth, or complications appear. ISSVA+1

  2. Patient/family education: Learn triggers (infection, trauma), warning signs, and the plan. Purpose: faster care and fewer complications. Mechanism: early response reduces airway risk, infection spread, and delayed treatment. ResearchGate+1

  3. Multidisciplinary vascular-anomalies clinic care: Care by ENT, interventional radiology, surgery, dermatology, genetics, and pediatrics. Purpose: best outcomes. Mechanism: correct classification + correct procedure choice reduces recurrence and complications. Neurointervention+1

  4. Airway safety plan: If the neck/throat is involved, doctors plan for difficult breathing events. Purpose: prevent emergency airway collapse. Mechanism: early evaluation and planning reduce life-threatening obstruction risk. ResearchGate+1

  5. Image-guided drainage (aspiration): A needle drains cyst fluid temporarily. Purpose: quick relief of pressure/pain. Mechanism: lowers cyst volume but often refills unless combined with sclerotherapy or other therapy. SAGE Journals+1

  6. Sclerotherapy (main non-surgical option): A specialist injects a “scar-making” liquid into cysts. Purpose: shrink cysts and symptoms. Mechanism: controlled irritation causes the cyst lining to close and collapse over time. SAGE Journals+1

  7. Staged sclerotherapy sessions: Many MLMs need more than one session. Purpose: safer gradual shrinkage. Mechanism: repeated treatments target separate cyst spaces and reduce sudden swelling from over-treatment. JVSVenous+1

  8. Surgery (planned excision/debulking): Used when the lesion is well-defined or causing major problems. Purpose: remove mass effect. Mechanism: physically removes cyst tissue; risk increases near nerves/vessels, so planning is key. JVSVenous+1

  9. Combined therapy (sclerotherapy + surgery): Common in large or mixed lesions. Purpose: better shrinkage with less nerve injury. Mechanism: sclerotherapy reduces size first, then surgery removes leftovers more safely. JVSVenous+1

  10. Laser or ablative procedures for surface leakage/blebs: For skin or mouth surface problems. Purpose: reduce oozing and irritation. Mechanism: seals tiny abnormal channels on the surface (not a cure for deep disease). JVSVenous+1

  11. Compression garments (selected cases): Helpful for swelling in limbs/body areas. Purpose: reduce fluid build-up and discomfort. Mechanism: external pressure improves lymph return and limits expansion of soft tissue swelling. ResearchGate+1

  12. Lymphedema therapy (manual lymph drainage): A trained therapist uses gentle massage. Purpose: swelling control. Mechanism: supports movement of lymph through healthier channels and reduces heaviness. ResearchGate+1

  13. Physiotherapy for function: Especially if movement is limited by size/pain. Purpose: maintain range of motion. Mechanism: guided exercises prevent stiffness and help daily activity despite swelling. ResearchGate+1

  14. Speech and feeding therapy (mouth/tongue lesions): Purpose: safer eating and clearer speech. Mechanism: training improves swallowing technique and reduces choking risk while medical treatment shrinks the lesion. ResearchGate+1

  15. Dental/ENT preventive care (oral lesions): Purpose: reduce infection and bleeding triggers. Mechanism: good oral hygiene lowers bacterial load; early treatment of mouth sores reduces swelling flare-ups. ResearchGate+1

  16. Skin care for irritation/leakage: Purpose: protect skin barrier. Mechanism: gentle cleansing and barrier creams reduce breakdown and lower infection entry points. ResearchGate+1

  17. Psychological support: Visible lumps can cause stress and bullying. Purpose: improve quality of life. Mechanism: counseling and coping skills reduce anxiety and improve treatment adherence. PMC+1

  18. School/social accommodations: Purpose: safe participation and confidence. Mechanism: planning for swelling days, pain control, and clinic visits reduces missed learning and stress. PMC+1

  19. Genetic counseling/testing (when recommended): Purpose: find pathway causes (like PIK3CA) that can guide therapy. Mechanism: confirmed molecular diagnosis can support targeted treatment decisions. FDA Access Data+1

  20. Emergency plan for sudden swelling: Purpose: faster urgent care for airway, eye, or severe pain events. Mechanism: clear steps reduce delays when rapid expansion happens from infection or bleeding. ResearchGate+1

Drug treatments

  1. Alpelisib (VIJOICE): Class: PI3K inhibitor. Dose (label): adults 250 mg once daily with food; ages 2–<18 50 mg once daily (possible increases in older children). Purpose: systemic therapy for severe PROS, which can include lymphatic malformations. Mechanism: blocks PI3K signaling to reduce abnormal overgrowth. Side effects: high blood sugar, diarrhea, mouth sores, rash, hypersensitivity. FDA Access Data

  2. Sirolimus (RAPAMUNE): Class: mTOR inhibitor (immunosuppressant). Dose: label dosing depends on indication and monitoring; clinicians use drug-level monitoring. Purpose (in LM care): often used off-label to shrink complex lymphatic anomalies. Mechanism: reduces mTOR-driven abnormal vessel growth/inflammation. Side effects: infection risk, mouth sores, high lipids, slow wound healing. FDA Access Data+1

  3. Everolimus (AFINITOR): Class: mTOR inhibitor. Dose: label is indication-specific. Purpose: sometimes considered off-label in vascular anomalies when mTOR pathway is involved. Mechanism: mTOR pathway suppression may reduce abnormal tissue growth. Side effects: infections, mouth ulcers, rash, lab changes. FDA Access Data+1

  4. Trametinib (MEKINIST): Class: MEK inhibitor. Dose: label is indication-specific. Purpose: used in some complex vascular/lymphatic anomalies in specialist centers (off-label). Mechanism: reduces MAPK pathway signaling in selected mutation-driven disease. Side effects: rash, diarrhea, heart/eye risks noted in labeling. FDA Access Data+1

  5. Selumetinib (KOSELUGO): Class: MEK inhibitor. Dose (label): 25 mg/m² twice daily (pediatric NF1 PN). Purpose: not approved for LM, but MEK inhibitors may be discussed when specific biology suggests benefit. Mechanism: blocks MEK signaling. Side effects: GI upset, skin effects, heart/eye warnings in label. FDA Access Data+1

  6. Bleomycin (BLENOXANE): Class: cytotoxic antibiotic (anticancer). Purpose in LM care: commonly used as a sclerotherapy agent (off-label route/dose). Mechanism: causes controlled injury/scarring of cyst lining to shrink it. Side effects: depends on route; label highlights serious toxicities in oncology use. FDA Access Data+1

  7. Doxycycline (VIBRAMYCIN IV): Class: tetracycline antibiotic. Purpose in LM care: also used as an intralesional sclerosant (off-label) and for infections when needed. Mechanism: for sclerotherapy, irritates cyst lining; for infection, blocks bacterial protein synthesis. Side effects: GI upset, sun sensitivity; tooth/bone concerns in young children per clinical guidance. FDA Access Data+1

  8. Sodium tetradecyl sulfate (SOTRADECOL): Class: sclerosing agent. Purpose: approved for varicose veins; sometimes used off-label in LM sclerotherapy. Mechanism: damages inner lining of the space, leading to closure. Side effects: local pain, inflammation; allergic reactions are possible. FDA Access Data+1

  9. Polidocanol (ASCLERA): Class: sclerosing agent. Purpose: approved for varicose veins; sometimes used off-label for vascular/lymphatic sclerotherapy. Mechanism: endothelial injury → closure/scarring. Side effects: injection-site reactions, rare allergic events. FDA Access Data+1

  10. Triamcinolone injection (KENALOG-10): Class: corticosteroid. Purpose: sometimes used locally to calm inflammation in selected lesions/areas (not a cure). Mechanism: reduces inflammatory swelling. Side effects: skin thinning, infection risk with steroids, systemic effects if repeated/high exposure. FDA Access Data

  11. Prednisone (RAYOS): Class: corticosteroid. Purpose: short courses may be used for severe inflammatory swelling when a doctor decides it is appropriate. Mechanism: lowers immune-driven inflammation. Side effects: mood changes, infection risk, blood sugar rise, stomach irritation (especially longer use). FDA Access Data

  12. Lidocaine (XYLOCAINE): Class: local anesthetic. Purpose: pain control during procedures (aspiration/sclerotherapy) and local numbing. Mechanism: blocks nerve sodium channels to stop pain signals. Side effects: heart/brain toxicity if too much enters blood; dosing is clinician-controlled. FDA Access Data

  13. Acetaminophen (IV label example): Class: analgesic/antipyretic. Purpose: pain/fever control during flare-ups or after procedures. Mechanism: central pain/fever reduction. Side effects: liver injury risk if overdosed or combined with other acetaminophen products. FDA Access Data+1

  14. Ibuprofen (MOTRIN label example): Class: NSAID. Purpose: pain and inflammation relief. Mechanism: COX inhibition lowers prostaglandins. Side effects: stomach irritation/bleeding risk, kidney strain, and (in some patients) heart risk—doctor guidance matters. FDA Access Data+1

  15. Ondansetron (ZOFRAN): Class: anti-nausea (5-HT3 blocker). Purpose: nausea/vomiting control after anesthesia or strong medicines. Mechanism: blocks serotonin signals that trigger vomiting. Side effects: constipation, headache; QT rhythm risk in some patients. FDA Access Data+1

  16. Amoxicillin/clavulanate (AUGMENTIN): Class: antibiotic (penicillin + beta-lactamase inhibitor). Purpose: treat secondary bacterial infections of skin/soft tissue when suspected/confirmed. Mechanism: blocks bacterial cell wall; clavulanate protects amoxicillin. Side effects: diarrhea, allergy, liver enzyme changes. FDA Access Data+1

  17. Clindamycin (CLEOCIN): Class: lincosamide antibiotic. Purpose: option for skin/soft-tissue infection or penicillin allergy. Mechanism: blocks bacterial protein synthesis. Side effects: diarrhea and C. difficile–associated colitis risk is a key warning. FDA Access Data+1

  18. Cefazolin (IV): Class: cephalosporin antibiotic. Purpose: commonly used around surgery/procedures or for susceptible skin infections (doctor-directed). Mechanism: blocks bacterial cell wall synthesis. Side effects: allergy, GI upset; dosing depends on age/weight/kidney function. FDA Access Data+1

  19. Vancomycin (IV): Class: glycopeptide antibiotic. Purpose: reserved for serious infections like suspected MRSA when needed. Mechanism: blocks bacterial cell wall building. Side effects: kidney risk, infusion reactions; careful monitoring is required. FDA Access Data+1

  20. Mupirocin ointment (BACTROBAN): Class: topical antibiotic. Purpose: treat small superficial bacterial skin infections or protect irritated skin breaks if prescribed. Mechanism: blocks bacterial protein production. Side effects: local burning/itching; avoid unnecessary use to limit resistance. FDA Access Data+1

Dietary molecular supplements (supportive; not a cure)

  1. Vitamin D: Dose depends on age and blood level; doctors may test first. Function: supports bone and immune function. Mechanism: helps calcium handling and immune signaling. Too much can be harmful, so avoid mega-doses. Office of Dietary Supplements

  2. Zinc: Function: supports immune function and wound healing. Mechanism: needed for many enzymes and immune cells. Too much zinc can cause nausea and can reduce copper absorption over time. Office of Dietary Supplements

  3. Vitamin C: Function: supports collagen formation and antioxidant defenses. Mechanism: helps tissue repair and immune cell work. High doses can cause stomach upset and diarrhea. Office of Dietary Supplements

  4. Omega-3 (EPA/DHA): Function: supports heart health and may lower inflammatory signaling. Mechanism: changes cell-membrane fats and inflammatory mediators. High doses can increase bleeding tendency in some people. Office of Dietary Supplements

  5. Magnesium: Function: supports muscle/nerve function and many enzymes. Mechanism: cofactor in energy and cell signaling. Too much (especially from supplements) can cause diarrhea. Office of Dietary Supplements

  6. Vitamin B12: Function: supports blood and nerve health. Mechanism: needed for DNA and red blood cell formation. Usually safe; deficiency is more common than toxicity. Office of Dietary Supplements

  7. Folate (folic acid): Function: supports cell growth and blood production. Mechanism: key for DNA building. Too much folic acid can hide B12 deficiency, so balance matters. Office of Dietary Supplements

  8. Selenium: Function: antioxidant defense and thyroid enzyme support. Mechanism: part of selenoproteins that protect cells. Too much can be toxic (hair/nail changes, GI symptoms). Office of Dietary Supplements

  9. Probiotics: Function: may help gut balance, especially after antibiotics. Mechanism: adds helpful microbes and changes gut immune signals. Some people (very ill/immunosuppressed) should avoid without doctor advice. Office of Dietary Supplements

  10. Vitamin A (only if deficient/doctor-directed): Function: supports skin and immune barriers. Mechanism: helps epithelial cell health. Too much vitamin A can be harmful, especially in pregnancy. Office of Dietary Supplements

Immunity / regenerative / stem-cell” drugs

There is no proven “stem-cell drug” cure for macrocystic lymphatic malformation in routine care; most “regenerative” ideas are still research. In real practice, doctors sometimes use medicines that modulate immune/inflammatory pathways or support patients during systemic therapy or serious infection risk. JVSVenous+1

  1. Sirolimus: Can lower abnormal vessel activity but is also an immunosuppressant, so infection monitoring matters. Function: pathway control in complex anomalies. Mechanism: mTOR inhibition. FDA Access Data+1

  2. Everolimus: Similar pathway idea (mTOR), used in selected specialist situations. Function: growth-signal reduction. Mechanism: mTOR inhibition. FDA Access Data+1

  3. Alpelisib (VIJOICE): Best example of targeted therapy when PROS is present. Function: reduces PI3K-driven overgrowth. Mechanism: PI3K inhibition. FDA Access Data

  4. Cefazolin (support during surgery/procedures): Not a “booster,” but it protects against bacterial infection when a doctor chooses it. Function: infection prevention/treatment. Mechanism: kills susceptible bacteria. FDA Access Data+1

  5. Vancomycin (support in serious infection): Used only when needed for resistant bacteria risk. Function: severe infection control. Mechanism: blocks cell wall formation. FDA Access Data+1

  6. Mupirocin (skin barrier support): Helps treat small skin infections that can trigger swelling episodes. Function: local infection control. Mechanism: blocks bacterial protein synthesis. FDA Access Data+1

Surgeries

  1. Complete excision (when possible): Surgeon removes the malformation. Why: best for well-localized lesions causing symptoms. JVSVenous+1

  2. Debulking (partial removal): Removes part of a large lesion. Why: reduce mass effect when full removal risks nerves/vessels. JVSVenous+1

  3. Staged surgery: More than one operation. Why: safer gradual removal and better cosmetic/functional outcome. JVSVenous+1

  4. Airway surgery (selected cases, e.g., tracheostomy): Why: protect breathing when swelling threatens airway or during complex treatment. ISSVA+1

  5. Laser/ablative surgery for mucosal disease (supportive): Why: reduce bleeding/leakage and improve function in mouth/tongue surface disease. JVSVenous+1

Preventions

  1. Treat colds/infections early to reduce swelling flares. ResearchGate+1

  2. Avoid trauma/pressure on the lump when possible. ISSVA+1

  3. Good skin care to prevent cracks and bacterial entry. ResearchGate+1

  4. Oral hygiene if mouth/tongue is involved. ResearchGate+1

  5. Follow imaging follow-ups so growth is caught early. Pediatric Interventional Radiology Handbook+1

  6. Use the clinic’s emergency plan for sudden swelling. ResearchGate+1

  7. Procedure aftercare (wound care, activity limits) as advised. JVSVenous+1

  8. Avoid unnecessary antibiotics (only when prescribed) to reduce resistance and side effects. FDA Access Data+1

  9. Vaccines as recommended (especially if on mTOR inhibitors that raise infection risk). FDA Access Data+1

  10. Healthy sleep and balanced diet to support healing and resilience. Office of Dietary Supplements+1

When to see a doctor (urgent vs soon)

Go urgently if there is breathing trouble, fast neck/throat swelling, blue lips, severe trouble swallowing, sudden eye/vision symptoms, high fever, severe redness/warmth, or severe pain, because infection or bleeding into the cyst can become dangerous quickly. See a doctor soon if the lump is growing, keeps coming back after drainage, leaks fluid, or affects daily life. ResearchGate+2ISSVA+2

What to eat and what to avoid

  1. Eat: enough protein (eggs, fish, beans) for healing; Avoid: very low-protein diets. Office of Dietary Supplements+1

  2. Eat: colorful fruits/vegetables; Avoid: skipping them most days. Office of Dietary Supplements+1

  3. Eat: omega-3 sources (fish, flax/chia); Avoid: frequent deep-fried foods. Office of Dietary Supplements

  4. Eat: fiber (whole grains, lentils); Avoid: constant ultra-processed snacks. Office of Dietary Supplements

  5. Eat: enough water; Avoid: dehydration (can worsen “feeling swollen”). ISSVA+1

  6. Eat: calcium/vitamin D foods if needed; Avoid: high-dose vitamin D without testing. Office of Dietary Supplements

  7. Eat: zinc foods (meat, legumes, nuts); Avoid: chronic high-dose zinc supplements. Office of Dietary Supplements

  8. Eat: foods gentle on the stomach during antibiotics; Avoid: alcohol and irritants if GI upset occurs. FDA Access Data+1

  9. Eat: soft foods during mouth swelling; Avoid: sharp/spicy foods if they worsen pain. ResearchGate+1

  10. Eat: balanced meals for stable weight; Avoid: extreme diets that reduce healing nutrients. Office of Dietary Supplements+1

FAQs

  1. Is macrocystic lymphatic malformation cancer? No, it is benign, but it can cause serious pressure symptoms. ISSVA+1

  2. Is it present from birth? Yes, it forms before birth, even if noticed later. ISSVA+1

  3. Why does it suddenly get bigger? Infection, inflammation, or bleeding into a cyst can cause fast swelling. ResearchGate+1

  4. What is the best test? MRI is often best for mapping extent; ultrasound is often the first test. Pediatric Interventional Radiology Handbook+1

  5. What is first-line treatment for macrocystic lesions? Often image-guided sclerotherapy. JVSVenous+1

  6. Will one procedure cure it? Sometimes, but many need staged sessions or combined therapy. JVSVenous+1

  7. Can it come back? Yes, recurrence can happen, especially with complex or mixed lesions. JVSVenous+1

  8. Is surgery always better than sclerotherapy? Not always; choice depends on location, size, and risk to nerves/vessels. JVSVenous+1

  9. Do antibiotics cure the malformation? No—antibiotics treat bacterial infection complications only. FDA Access Data+1

  10. Can targeted drugs help? In selected severe cases (especially PROS), drugs like alpelisib may help under specialists. FDA Access Data+1

  11. Is sirolimus approved for lymphatic malformation? It is widely used off-label for complex lymphatic anomalies; it is an immunosuppressant and needs monitoring. FDA Access Data+1

  12. Are supplements a cure? No. They may support general health but do not remove the malformation. Office of Dietary Supplements+1

  13. Can children live a normal life with MLM? Many do, especially with proper treatment and follow-up. ResearchGate+1

  14. When is it an emergency? Any breathing trouble, fast neck swelling, high fever/redness, or severe pain needs urgent care. ResearchGate+1

  15. Which specialist should I see? A vascular anomalies clinic (ENT + interventional radiology + surgery) is often ideal. JVSVenous+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 14, 2025.

PDF Documents For This Disease Condition

  1. Rare Diseases and Medical Genetics.[rxharun.com]
  2. i2023_IFPMA_Rare_Diseases_Brochure_28Feb2017_FINAL.[rxharun.com]
  3. the-UK-rare-diseases-framework.[rxharun.com]
  4. National-Recommendations-for-Rare-Disease-Health-Care-Summary.[rxharun.com]
  5. History of rare diseases and their genetic.[rxharun.com]
  6. health-care-and-rare-disorders.[rxharun.com]
  7. Rare Disease Registries.[rxharun.com]
  8. autoimmune-Rare-Genetic-Diseases.[rxharun.com]
  9. Rare Genetic Diseases.[rxharun.com]
  10. rare-disease-day.[rxharun.com]
  11. Rare_Disease_Drugs_e.[rxharun.com]
  12. fda-CDER-Rare-Diseases-Public-Workshop-Master.[rxharun.com]
  13. rare-and-inherited-disease-eligibility-criteria.[rxharun.com]
  14. FDA-rare-disease-list.pdf-rxharun.com1 Human-Gene-Therapy-for-Rare Diseases_Jan_2020fda.[rxharun.com]
  15. FDA-rare-disease-lists.[rxharun.com]
  16. 30212783fnl_Rare Disease.[rxharun.com]
  17. FDA-rare-disease-list.[rxharun.com]
  18. List of rare disease.[rxharun.com]
  19. Genome Res.-2025-Steyaert-755-68.[rxharun.com]
  20. uk-practice-guidelines-for-variant-classification-v4-01-2020.[rxharun.com]
  21. PIIS2949774424010355.[rxharun.com]
  22. hidden-costs-2016.[rxharun.com]
  23. B156_CONF2-en.[rxharun.com]
  24. IRDiRC_State-of-Play-2018_Final.[rxharun.com]
  25. IRDR_2022Vol11No3_pp96_160.[rxharun.com]
  26. from-orphan-to-opportunity-mastering-rare-disease-launch-excellence.[rxharun.com]
  27. Rare disease fda.[rxharun.com]
  28. England-Rare-Diseases-Action-Plan-2022.[rxharun.com]
  29. SCRDAC 2024 Report.[rxharun.com]
  30. CORD-Rare-Disease-Survey_Full-Report_Feb-2870-2.[rxharun.com]
  31. Stats-behind-the-stories-Genetic-Alliance-UK-2024.[rxharun.com]
  32. rare-and-inherited-disease-eligibility-criteria-v2.[rxharun.com]
  33. ENG_White paper_A4_Digital_FINAL.[rxharun.com]
  34. UK_Strategy_for_Rare_Diseases.[rxharun.com]
  35. MalaysiaRareDiseaseList.[rxharun.com]
  36. EURORDISCARE_FULLBOOKr.[rxharun.com]
  37. EMHJ_1999_5_6_1104_1113.[rxharun.com]
  38. national-genomic-test-directory-rare-and-inherited-disease-eligibilitycriteria-.[rxharun.com]
  39. be-counted-052722-WEB.[rxharun.com]
  40. RDI-Resource-Map-AMR_MARCH-2024.[rxharun.com]
  41. genomic-analysis-of-rare-disease-brochure.[rxharun.com]
  42. List-of-rare-diseases.[rxharun.com]
  43. RDI-Resource-Map-AFROEMRO_APRIL[rxharun.com]
  44. rdnumbers.[rxharun.com] .
  45. Rare disease atoz .[rxharun.com]
  46. EmanPublisher_12_5830biosciences-.[rxharun.com]

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK208609/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6279436/
  3. https://rarediseases.org/rare-diseases/
  4. https://rarediseases.info.nih.gov/diseases
  5. https://en.wikipedia.org/w/index.php?title=Category:Rare_diseases
  6. https://en.wikipedia.org/wiki/List_of_genetic_disorders
  7. https://en.wikipedia.org/wiki/Category:Genetic_diseases_and_disorders
  8. https://medlineplus.gov/genetics/condition/
  9. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  10. https://www.fda.gov/patients/rare-diseases-fda
  11. https://www.fda.gov/science-research/clinical-trials-and-human-subject-protection/support-clinical-trials-advancing-rare-disease-therapeutics-start-pilot-program
  12. https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.2134
  13. https://www.mayoclinicproceedings.org/article/S0025-6196%2823%2900116-7/fulltext
  14. https://www.ncbi.nlm.nih.gov/mesh?
  15. https://www.rarediseasesinternational.org/working-with-the-who/
  16. https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03322-7
  17. https://www.rarediseasesnetwork.org/
  18. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rare-disease
  19. https://www.raregenomics.org/rare-disease-list
  20. https://www.astrazeneca.com/our-therapy-areas/rare-disease.html
  21. https://bioresource.nihr.ac.uk/rare
  22. https://www.roche.com/solutions/focus-areas/neuroscience/rare-diseases
  23. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  24. https://www.genomicsengland.co.uk/genomic-medicine/understanding-genomics/rare-disease-genomics
  25. https://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/
  26. https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01026
  27. https://wikicure.fandom.com/wiki/Rare_Diseases
  28. https://www.wikidoc.org/index.php/List_of_genetic_disorders
  29. https://www.medschool.umaryland.edu/btbank/investigators/list-of-disorders/
  30. https://www.orpha.net/en/disease/list
  31. https://www.genetics.edu.au/SitePages/A-Z-genetic-conditions.aspx
  32. https://ojrd.biomedcentral.com/
  33. https://health.ec.europa.eu/rare-diseases-and-european-reference-networks/rare-diseases_en
  34. https://bioportal.bioontology.org/ontologies/ORDO
  35. https://www.orpha.net/en/disease/list
  36. https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions
  37. https://www.gao.gov/products/gao-25-106774
  38. https://www.gene.com/partners/what-we-are-looking-for/rare-diseases
  39. https://www.genome.gov/For-Patients-and-Families/Genetic-Disorders
  40. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  41. https://my.clevelandclinic.org/health/diseases/21751-genetic-disorders
  42. https://globalgenes.org/rare-disease-facts/
  43. https://www.nidcd.nih.gov/directory/national-organization-rare-disorders-nord
  44. https://byjus.com/biology/genetic-disorders/
  45. https://www.cdc.gov/genomics-and-health/about/genetic-disorders.html
  46. https://www.genomicseducation.hee.nhs.uk/doc-type/genetic-conditions/
  47. https://www.thegenehome.com/basics-of-genetics/disease-examples
  48. https://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/
  49. https://www.pfizerclinicaltrials.com/our-research/rare-diseases
  50. https://clinicaltrials.gov/ct2/results?recrs
  51. https://apps.who.int/gb/ebwha/pdf_files/EB116/B116_3-en.pdf
  52. https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239
  53. https://www.nibib.nih.gov/
  54. https://www.nei.nih.gov/
  55. https://oxfordtreatment.com/
  56. https://www.nidcd.nih.gov/health/https://consumer.ftc.gov/articles/
  57. https://www.nccih.nih.gov/health
  58. https://catalog.ninds.nih.gov/
  59. https://www.aarda.org/diseaselist/
  60. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets
  61. https://www.nibib.nih.gov/
  62. https://www.nia.nih.gov/health/topics
  63. https://www.nichd.nih.gov/
  64. https://www.nimh.nih.gov/health/topics
  65. https://www.nichd.nih.gov/
  66. https://www.niehs.nih.gov/
  67. https://www.nimhd.nih.gov/
  68. https://www.nhlbi.nih.gov/health-topics
  69. https://obssr.od.nih.gov/.
  70. https://www.nichd.nih.gov/health/topics
  71. https://rarediseases.info.nih.gov/diseases
  72. https://beta.rarediseases.info.nih.gov/diseases
  73. https://orwh.od.nih.gov/

 

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.

References

Add references, clinical guidelines, textbooks, journal articles, or trusted medical sources here. You can edit this area later with a custom field named _rx_references.

Related Articles

Written by Dr. Harun Ar Rashid, MD - Arthritis, Bones, Joints Pain, Trauma, and Internal Medicine Specialist

Dr. Md. Harun Ar Rashid, MPH, MD, PhD, is a highly respected medical specialist celebrated for his exceptional clinical expertise and unwavering commitment to patient care. With advanced qualifications including MPH, MD, and PhD, he integrates cutting-edge research with a compassionate approach to medicine, ensuring that every patient receives personalized and effective treatment. His extensive training and hands-on experience enable him to diagnose complex conditions accurately and develop innovative treatment strategies tailored to individual needs. In addition to his clinical practice, Dr. Harun Ar Rashid is dedicated to medical education and research, writing and inventory creative thinking, innovative idea, critical care managementing make in his community to outreach, often participating in initiatives that promote health awareness and advance medical knowledge. His career is a testament to the high standards represented by his credentials, and he continues to contribute significantly to his field, driving improvements in both patient outcomes and healthcare practices. Born and educated in Bangladesh, Dr. Rashid earned his BPT from the University of Dhaka before pursuing postgraduate training internationally. He completed his MD in Internal Medicine at King’s College London, where he developed a special interest in inflammatory arthritis and metabolic bone disease. He then undertook a PhD in Orthopedic Science at the University of Oxford, conducting pioneering research on cytokine signaling pathways in rheumatoid arthritis. Following his doctoral studies, Dr. Rashid returned to clinical work with a fellowship in interventional pain management at the Rx University School of Medicine, refining his skills in image-guided joint injections and minimally invasive pain-relief techniques.